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Abstract
Background: Mechanical overload of the heart is associated with excessive deposition of extracellular matrix
proteins and the development of cardiac fibrosis. This can result in reduced ventricular compliance, diastolic
dysfunction, and heart failure. Extracellular matrix synthesis is regulated primarily by cardiac fibroblasts, more
specifically, the active myofibroblast. The influence of mechanical stretch on human cardiac fibroblasts’ response to
pro-fibrotic stimuli, such as transforming growth factor beta (TGFβ), is unknown as is the impact of stretch on B-
type natriuretic peptide (BNP) and natriuretic peptide receptor A (NPRA) expression. BNP, acting via NPRA, has been
shown to play a role in modulation of cardiac fibrosis.
Methods and results: The effect of cyclical mechanical stretch on TGFβ induction of myofibroblast differentiation
in primary human cardiac fibroblasts and whether differences in response to stretch were associated with changes
in the natriuretic peptide system were investigated. Cyclical mechanical stretch attenuated the effectiveness of
TGFβ in inducing myofibroblast differentiation. This finding was associated with a novel observation that
mechanical stretch can increase BNP and NPRA expression in human cardiac fibroblasts, which could have
important implications in modulating myocardial fibrosis. Exogenous BNP treatment further reduced the potency of
TGFβ on mechanically stretched fibroblasts.
Conclusion: We postulate that stretch induced up-regulation of the natriuretic peptide system may contribute to
the observed reduction in myofibroblast differentiation.
Keywords: Mechanical stretch, BNP, Natriuretic peptide receptor A, Transforming growth factor beta, Myofibroblast,
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Background
Hypertensive heart disease describes a phase of remodel-
ing which occurs in the myocardium when exposed to
sustained elevation in arterial blood pressure or hyper-
trophic substances associated with the hypertension syn-
drome. The two most notable features of hypertensive
heart disease are myocyte hypertrophy and reactive
fibrosis. The relationship between reactive fibrosis and
hypertension is well described [1-3].
In physiological terms, the effect of this fibrosis is a re-
duction in compliance of the myocardium and diastolic
dysfunction. This premise is based on two principles.
Firstly, the addition of fibrillar collagen to normal tissue
results in reduced compliance of that tissue, and sec-
ondly, regression of such fibrosis improves compliance
and reduces cardiac stiffness [4-8]. The synthesis and
degradation of fibrillar collagen is regulated by the myo-
cardial fibroblast. Fibroblast differentiation to the more
active myofibroblast form is a hallmark of cardiac
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fibrosis, and is associated with increased collagen pro-
duction, enhanced proliferative and migratory potential,
and is associated with increased expression of alpha-
smooth muscle actin (ASMA) [9]. Although myofibro-
blast differentiation is an essential process required for
normal wound healing, prolonged injury or perhaps loss
of regulation can result in pathological fibrosis.
Modulation of pro-fibrotic signals within the myocar-
dium is necessary to regulate normal wound healing pro-
cesses. One possible regulator may be B-type natriuretic
peptide (BNP). BNP is an endogenous hormone which is
known to be secreted by cardiac myocytes in response to
myocardial stretch and overload and is an important regu-
lator of blood volume homeostasis through its diuretic,
natriuretic, and vasodilating actions and by inhibiting
renin and aldosterone [10,11]. More recent data suggest
that natriuretic peptides also appear to play a major role
in modulation of both cardiac and renal fibrosis [12-14].
The aim of this study was to investigate the combined
effects of mechanical stretch and the pro-fibrotic cytokine
transforming growth factor beta (TGFβ) on myofibroblast
differentiation, and the impact of BNP in this process.
Results
The impact of mechanical stretch on human primary car-
diac fibroblast cells response to recombinant TGFβ was
investigated. These experiments were carried out on flex-
ible six well culture plates coated with 2 μg/cm2 human
fibronectin, as described in the Methods section. Cells at a
confluency of approximately 70% were exposed to cyclic
equibiaxial Heart Simulation strain (1 Hz, maximum
elongation 10%) for 72 h. Control plates were exposed to
the same conditions without being stretched. These
experiments were carried out either in the presence or ab-
sence of 10 ng/mL recombinant TGFβ.
TGFβ-induced ASMA and collagen 1 is reduced on
mechanically stretched cardiac fibroblast cells
The combined effects of mechanical stretch and TGFβ
treatment on human primary cardiac fibroblast expres-
sion of the differentiation marker ASMA and the pro-
fibrotic markers collagen 1 and 3 were investigated.
Quantitative real-time PCR analysis revealed that TGFβ
induction of ASMA gene expression was significantly
reduced on stretched cells. TGFβ treatment for 72 h on
non-stretched cells up-regulated ASMA by over 15-fold,
whereas TGFβ stimulated ASMA expression was only
two-fold in stretched cells, P< 0.001 (Figure 1A). A
similar response was detected for collagen 1, where
TGFβ induction of collagen 1 gene expression was
reduced from approximately four-fold to two-fold when
cells were mechanically stretched compared to non-
stretched cells, P< 0.001 (Figure 1A). Interestingly, un-
like ASMA and collagen1, TGFβ induction of collagen 3
expression was significantly enhanced when cells were
mechanically stretched, P< 0.05. Due to the magnitude
of the suppressive effects of stretch on TGFβ up-
regulation of ASMA, this observation was verified at the
protein level by Western blotting, where TGFβ induced
ASMA was significantly diminished in stretched cells,
P< 0.001 (Figure 1B).
Diminished responses to exogenous TGFβ on mechanially
stretched cardiac fibroblast cells are not due to decreased
basal expression levels of TGFβ
The impact of cyclical mechanical stretch on basal and
TGFβ stimulated expression of TGFβ, and its receptor
subtypes 1 and 2 (TGFβ-R1; TGFβ-R2) were investigated.
Human cardiac fibroblast cells underwent mechanical
stretch for 72 h in the presence or absence of 10 ng/mL
TGFβ. Quantitative gene expression analysis revealed that
mechanical stretch did not alter the levels of TGFβ recep-
tors (Figure 2A). However, mechanical stretch did impact
the basal expression levels of TGFβ. A significant 2.5-fold
increase in gene expression was observed (P< 0.05)
(Figure 2A). Further evidence that the diminished re-
sponse to exogenous TGFβ on mechanically stretched
cells was not due to reduced basal expression of TGFβ, or
its receptors, is shown in Figure 2B. A reduction in Smad2
phosphorylation was not observed under stretched condi-
tions. Of note, treatment with TGFβ in stretched cells
resulted in a 10-fold increase in basal expression of TGFβ
gene expression (P< 0.01), Figure 2C, but had no impact
on expression of its receptors (data not shown). The im-
pact of mechanical stretch and recombinant TGFβ treat-
ment on HCF production of TGFβ protein production
was investigated. Both total and active TGFβ1 was quanti-
fied in the supernatant of HCF using ELISA based meth-
ods (Figure 2D). The relatively large increase in TGFβ
mRNA expression in cells exposed to mechanical stretch
and recombinant TGFβ stimulation was not reflected at
the protein level. The highest concentration of secreted
TGFβ protein (both latent and active) was in un-stretched
cardiac fibroblast cells stimulated with recombinant TGFβ
treatment for 72 h. The impact of stretch alone did not
have a significant impact on TGFβ secretion (although a
downward trend was apparent). However, the ability of re-
combinant TGFβ to stimulate endogenous TGFβ produc-
tion was reduced when the cells were mechanically
stretched. Interestingly however, it is important to note that
the detectable levels of secreted TGFβ were <1 pg/mL,
thus the physiological relevance of these small changes
within the experimental cell culture environment is un-
known, especially under conditions of recombinant TGFβ
treatment were cells are exposed to 10,000x this
concentration.
Collectively, these data suggest that the observed re-
duction in TGFβ-mediated myofibroblast differentiation
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on mechanically stretched cells does not occur through
a reduction in gene expression levels of TGFβ or recep-
tor subtype 1 or 2. Concentration differences in secreted
TGFβ are minimal and are unlikely to be responsible for
the observed reduction of TGFβ induction of ASMA in
stretched cells highlighted in Figure 1. This is further
supported by intact Smad2 and ERK phosphorylation in
response to short time point stimulation with TGFβ (15
and 45 min) post 72 h mechanical stretch.
Mechanical stretch up-regulates both BNP and its
receptor NPRA in primary human cardiac fibroblast cells
Cardiac fibroblast cells exposed to mechanical stretch
for 72 h exhibited a significant increase in gene expres-
sion of BNP and its receptor natriuretic peptide receptor
A (NPRA). BNP and NPRA were significantly up-
regulated by over 25-fold (P< 0.001) and almost four-
fold (P< 0.01), respectively (Figure 3A). TGFβ treatment
in non-stretched conditions did not significantly impact
BNP or NPRA gene expression levels. Interestingly,
TGFβ treatment in the presence of stretch further
increased the expression level of BNP. A trend towards a
negative impact of TGFβ treatment on NPRA gene ex-
pression was observed. NPRA protein expression was
apparent in both non-stretched and stretched fibroblast
cells by immunofluorescence microscopy. However, the
intensity of positive immuno-staining was greater in cells
that underwent mechanical stretch (Figure 3B). Quanti-
tative evidence of increased NPRA protein expression in
stretched cardiac fibroblasts was observed using western
Figure 1 Mechanical stretch reduces TGFβ induction of alpha-smooth muscle actin (ASMA) and collagen 1 expression in human
cardiac fibroblasts. Human primary cardiac fibroblasts underwent either biaxial mechanical stretch for 72 h or were left un-stretched (control), in
the presence of 10 ng/mL transforming growth factor beta (TGFβ). Alterations in ASMA, collagen 1, and collagen 3 gene expression were
examined using quantitative real-time PCR analysis (A). Western blotting was used to quantify changes in ASMA protein expression (B). Anti-
tubulin was utilized as a loading control for western blotting, allowing for semi-quantitative densitometry analysis. Bar graphs represent mean
fold change± SD. *P< 0.05, **P< 0.01, ***P< 0.001.
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blotting. NPRA protein expression was up-regulated
more than two-fold following 72 h of mechanical
stretching (P< 0.01) (Figure 3C). Cell lysates derived
from transient over-expression of NPRA served as a
positive control.
Exogenous BNP further reduces the pro-fibrotic effects of
TGFβ on stretched primary human cardiac fibroblast cells
The reduced potency of TGFβ to induce myofibroblast
differentiation on stretched cardiac fibroblasts was fur-
ther investigated in the context of stretch induced BNP
and NPRA expression. The impact of recombinant BNP
treatment in combination with TGFβ on stretched cells
was explored. It was found that the anti-fibrotic effects
of exogenous BNP, as measured by ASMA protein re-
pression, were only apparent when cardiac fibroblasts
were mechanically stretched for 72 h (Figure 4).
Discussion
TGFβ is a powerful mediator of adverse cardiac remod-
eling and fibrosis primarily via Smad-dependent induc-
tion of collagen expression as well as differentiation of
fibroblasts to the myofibroblast phenotype which exhi-
bits increased secretory, migratory, and proliferative
properties and express the contractile protein ASMA
[15-18]. The current study presents a novel observation
that the pro-fibrotic effects of TGFβ are reduced on
mechanically stretched human primary cardiac fibroblasts.
Figure 2 Mechanical stretch does not reduce basal TGFβ expression in human cardiac fibroblast cells. Human primary cardiac fibroblast
cells underwent either biaxial mechanical stretch for 72 h or were left un-stretched (control), in the presence or absence of 10 ng/mL
transforming growth factor beta (TGFβ). Analysis of stretch induced basal gene expression changes of TGFβ, TGFβ receptor type-1 (TGFβ-R1), and
TGFβ receptor type-2 (TGFβ-R2) by quantitative real-time PCR are highlighted (A). Presented gene expression fold changes in Figure A are
independent of recombinant TGFβ treatment and represent the impact of mechanical stretch alone. Western blot analysis of the impact of 72 h
of mechanical stretch on TGFβ induced phosphorylation of Smad2 and ERK protein expression (B). Quantitative real-time PCR analysis of the
effect of exogenous TGFβ treatment on basal TGFβ expression (C). The impact of mechanical stretch and recombinant TGFβ treatment on cardiac
fibroblast production and secretion of total and active TGFβ protein was assessed using ELISA-based methods (D). Bar graphs represent mean
fold change± SD. *P< 0.05, **P< 0.01.
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In addition to this, we also document for the first time
that mechanical stretch can up-regulate BNP and NPRA
expression in human primary cardiac fibroblast cells,
which could have important implications in modulating
myocardial fibrosis. This point is emphasized by the
observed increased anti-fibrotic effect of exogenous BNP
treatment on stretched fibroblasts.
Within a normal or exaggerated wound healing envir-
onment additional stimuli are present along with pro-
fibrotic factors such as TGFβ which may impact cellular
activities. These may include the impact of tissue ische-
mia, circulating neuro-hormonal factors, or mechanical
stretch on cellular behavior. A pressure or volume over-
loaded heart may exert increased mechanical strain at a
cellular level. In combination with a pro-fibrotic envir-
onment, these additional heart stresses may impact dis-
ease progression, such as cardiac fibrosis and tissue
remodeling.
One component of this study was to determine
whether the impact of TGFβ on primary human cardiac
fibroblasts was different on mechanically stretched cells
compared with static cells. Surprisingly, we found that
TGFβ induced ASMA expression was reduced when
cells underwent cyclical stretch compared to static cells.
This was also apparent for collagen 1 gene expression,
but not collagen 3. Based on previous work using vari-
ous cardiovascular cell types from a range of animal spe-
cies, we anticipated that the combination of mechanical
stretch and TGFβ treatment would have increased
ASMA and collagen 1 expression compared with TGFβ
treated static cells resulting in an enhanced pro-fibrotic
effect [19-21]. Interestingly, our finding that mechanical
stretch reduces myofibroblast differentiation has recently
been supported by similar observations in primary lung
fibroblasts [22]. Here, Blaauboer et al. investigated the
impact of sinusoidal stretch on lung fibroblast response
to TGFβ. The authors suggest that their observed reduc-
tion in the ability of exogenous TGFβ to induce ASMA
was due to a stretch mediated down-regulation of basal
TGFβ gene expression. However, we do not observe this
in our system with primary human cardiac fibroblast
cells. In fact, we observe an increase in basal levels of
TGFβ gene expression. However, when examining the
protein levels of TGFβ produced and released by the
HCF, it was observed that the ability of recombinant
TGFβ to stimulate endogenous TGFβ production was
reduced when the cells were mechanically stretched. It is
important to note that the detectable levels of secreted
Figure 3 Mechanical stretch up-regulates BNP and natriuretic peptide receptor A (NPRA) in human cardiac fibroblasts. Human primary
cardiac fibroblast cells underwent either biaxial mechanical stretch for 72 h or were left un-stretched (control) in the presence or absence of
10 ng/mL recombinant TGFβ. Changes in gene expression of b-type natriuretic peptide (BNP) and its receptor NPRA were investigated using
quantitative real-time PCR (A). Further evidence that mechanical stretch has the ability to up-regulate NPRA is demonstrated at the protein level
in the absence of TGFβ stimulation. Increased NPRA protein on stretched cardiac fibroblasts is evident, as shown by immunofluorescent
microscopy (B). The intensity of NPRA immunofluorescence (red) is greater in cells mechanically stretched for 72 h compared to un-stretched
(control) cells. The nuclei of cells were counterstained using DAPI (blue). Images were captured (Zeiss Axio Imager M1), at the same exposure
time for comparison. Stretch-induced (72 h) up-regulation of NPRA protein was measured by western blotting and quantified using densitometry
(C). Protein extracted from HEK-293-T cells over-expressing NPRA were used as a positive control (+ve). Bar graphs represent mean fold
change± SD. **P< 0.01, ***P< 0.001.
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TGFβ were <1 pg/mL, which likely rules out a paracrine
effect of TGFβ released from the HCF being the driver
of the reduced myofibroblast differentiation in the pres-
ence of stretch and recombinant TGFβ. Within an
in vivo setting the main source of TGFβ driving myofi-
broblast differentiation in the myocardium is from other
cell types, including the tissue invading inflammatory
cell component and cardiomyocytes [23-26].
As we do not detect reduced levels of TGFβ, or its re-
ceptor subtypes TGFβ-R1 and TGFβ-R2 gene expres-
sion, minimally detectable levels of secreted active or
total TGFβ within the cells supernatant (<1 pg/mL) or
reduced Smad 2 phosphorylation, we believe that
stretch-mediated inhibition of TGFβ-induced cardiac
fibroblast differentiation occurs independently of TGFβ
receptor signaling or downstream of Smad 2. One alter-
native mechanism may involve ERK signaling as it has
recently been reported that TGFβ mediated ERK phos-
phorylation under conditions of cyclical stretching can
be impaired [27]. However, we do not observe reduced
ERK phosphorylation when comparing the impact of
short time point (15 and 45 min) TGFβ stimulation in
cells that have been stretched for 72 h vs. non-stretched
cells. Investigating the impact of chronic stimulation
with TGFβ on ERK phosphorylation under mechanical
stretch conditions would be of interest.
In parallel to stretch-induced attenuation of TGFβ re-
sponse, we report an important novel observation that
mechanical stretch can up-regulate the expression of
both BNP and its receptor NPRA in human cardiac
fibroblast cells. In addition, TGFβ stimulation in the
presence of mechanical stretch can further enhance the
observed BNP up-regulation. BNP has been reported to
be synthesized in both animal and human cardiac fibro-
blasts [28-30], however the impact of stretch on its ex-
pression in these cells has not been noted to date. In
addition, the impact of mechanical stretch on fibroblast
expression of NPRA has not been explored. Although
up-regulation of BNP expression following mechanical
stretch of cardiomyocytes is well-documented, it is only
more recently that mechanisms of this are being teased
out. For example, a publication by Koivisto and collea-
gues highlight an important observation that ERK
mediated activation of the muscle-CAT (MCAT) pro-
moter element within the BNP gene contributes to
stretch induced BNP up-regulation in cardiomyocytes
[31]. Determining whether similar mechanisms occur in
myofibroblasts would be important, however, MCAT ac-
tivation within this cell type may be mediated by a dif-
ferent means [32].
These two observations that mechanical stretch can
up-regulate BNP and NPRA in cardiac fibroblasts have
important implications on our understanding of fibro-
blast biology in the context of the fibro-inhibitory effects
of BNP [13,28]. Given that NPRA has recently been
shown to play a protective role in an animal model of
renal fibrosis [14] the relevance of stretch-regulated
NPRA expression may extend to other organ systems.
Although we do not show that endogenous production
of BNP and enhanced NPRA expression directly
accounts for attenuation of the TGFβ response, we do
provide evidence that the anti-fibrotic effects of BNP are
enhanced in stretched cells in line with the increase in
NPRA expression. Western blot analysis of ASMA
revealed that the observed inhibition of TGFβ-induced
ASMA on stretched cardiac fibroblasts was further
enhanced in the presence of exogenous recombinant
BNP. Although exogenous BNP inhibits ASMA mRNA
expression in static cardiac fibroblasts (data not shown)
we demonstrate here that it has little effect on ASMA
protein expression. Presumably this is due to the rela-
tively low expression of NPRA on un-stretched cardiac
fibroblasts. The impact of exogenous BNP on cardiac
fibroblast function is highly relevant, given that the ma-
jority of BNP encountered by cardiac fibroblasts is likely
to originate from the cardiomyocytes. However, fibro-
blast production of BNP may have an autocrine/
Figure 4 Treatment with exogenous BNP further reduces the
pro-fibrotic effects of TGFβ on mechanically stretched
fibroblasts. Human primary cardiac fibroblast cells underwent either
biaxial mechanical stretch for 72 h or were left un-stretched
(control). During this time, cells were either exposed to 10 ng/mL
transforming growth factor beta (TGFβ) or 1,000 nM recombinant b-
type natriuretic peptide (BNP), or both. Changes in alpha-smooth
muscle actin (ASMA) protein expression were measured using
western blotting and quantified using densitometry. Anti-tubulin
was utilized as a loading control for western blotting. Bar graphs
represent mean fold change± SD. ***P< 0.001.
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paracrine effect and provide regulation at a local level.
This could be particularly important in scar tissue, were
fibroblast cells are isolated from neighboring myocytes
within a sea of collagen.
Further work is required to delineate the precise
mechanisms behind our findings, including the investi-
gation of additional experimental time points, concen-
tration of agonists used, and degree of mechanical
stretch applied. Under normal physiological conditions,
cardiac fibroblasts are exposed to cyclical mechanical
stretch with each heart beat, at a frequency of approxi-
mately 1 Hz. Given the different cellular responses
observed in this study when cells are exposed to cyclical
mechanical stretch compared with static cells, additional
studies expanding these observations in an enhanced
pathological setting are warranted. In particular, it may
be worth assessing the impact of increasing the degree
of mechanical strain beyond 10% elongation or varying
the level of TGFβ stimulation on the findings reported
herein. Application of continuous cyclical mechanical
stretch for durations beyond 72 h may provide a more
accurate representation of hypertensive heart disease
which is a chronic condition that exposes the myocar-
dium to long periods of strain.
On this note, it must be highlighted that this study uti-
lized one primary cell line from a healthy donor, and
therefore to investigate these findings further one would
need to take a more comprehensive approach using mul-
tiple primary cells lines from various donors spanning
the age and cardiovascular health spectrum. It is possible
that cardiac fibroblasts derived from a disease myocar-
dium may behave differently, for example, the pathway
controlling stretch up-regulation of BNP or NPRA may
not be functional in diseased fibroblasts.
An additional benefit of using multiple primary cell
lines from various donors would be to determine
whether our observed findings are applicable to an array
of phenotypically diverse fibroblast cells across the
spectrum of myofibroblast differentiation. Extensive
work carried out by Gabbiani and colleagues has high-
lighted an important intermediate phenotype between a
fibroblast and a myofibroblast, termed the proto-
myofibroblast [21,33]. The evolution of a fibroblast to a
proto-myofibroblast is signified by the presence of beta
and gamma actin stress fibers, with the development of
cytoplasmic ASMA fibers only appearing in the fully dif-
ferentiated myofibroblast [21,33]. The primary cardiac
fibroblasts used in this study exhibited basal mRNA and
protein expression of the contractile protein ASMA,
however, ASMA stress fibers were not detected in con-
trol cells by immunocytochemistry (data not shown). It
is therefore likely that these primary cells are on the
continuum between a phenotypic fibroblast and a myofi-
broblast, and therefore may be more appropriately
referred to as ‘proto-myofibroblasts’. With this in mind,
the observed responses to mechanical stimuli herein
may only be relevant to proto-myofibroblasts. This could
also account for some of the conflicting findings with
current literature as previously mentioned [19-21].
Cellular interpretation of a mechanical stimulus is
likely to be influenced by the surrounding extracellular
matrix, thus investigating the importance of integrin sig-
naling during stretched cardiac fibroblast’s response to
TGFβ and BNP should be considered [29,34,35]. For ex-
ample, it is possible that the cellular responses we
observed may be specific to cardiac fibroblasts interact-
ing with extracellular matrix proteins containing RGD
(Arg-Gly-Asp) domains, such as fibronectin and collagen
IV [29,36]. Interestingly, NPRA has been demonstrated
to interact with RGD-binding integrin receptors thereby
enhancing BNP activation of cGMP in human cardiac
fibroblasts [29,36].
Conclusion
In summary, our data expand on the complex relation-
ship between mechanical strain and cell/matrix interac-
tions and human cardiac fibroblast physiology. We
demonstrate that cell deformation via cyclical biaxial
strain attenuates the effectiveness of TGFβ in inducing
myofibroblast differentiation while simultaneously indu-
cing BNP and NPRA production in human cardiac fibro-
blast cells. We confirm the inhibitory properties of BNP
on TGFβ regulation of the myofibroblast differentiation
marker ASMA and show that exogenous BNP treatment
of stretched fibroblasts further reduces the potency of
TGFβ. We postulate that the stretch-induced up-
regulation of the natriuretic peptide system could ac-
count for these findings. These findings may describe a
novel protective negative feedback mechanism for car-
diac fibroblasts exposed to multiple pro-fibrotic stimuli
and would encourage future work to directly link this
observation, possibly through the use of siRNA experi-
ments or NPRA receptor antagonists.
Methods
Cell culture
Primary human cardiac fibroblast cells from the adult
ventricle (HCF) were purchased from ScienCell Research
Laboratories. Primary cells were derived from a single
female donor aged 20 years. Until required for experi-
ments, cells were cultured and maintained in Dulbecco’s
modified eagles medium (DMEM) (Gibco), supplemen-
ted with 10% fetal bovine serum (Gibco) and penicillin-
streptomycin antibiotics (Gibco) in a 5% CO2 humidified
incubator kept at 37 °C. All experiments involving car-
diac fibroblasts were carried out under serum-free
conditions.
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Transfection
HEK-293-T cells were used to generate a positive control
for natriuretic peptide receptor A (NPRA; also known as
guanylyl cyclase A, GCA) expression. Cells were pur-
chased from American Type Culture Collection (ATCC)
and were cultured in DMEM supplemented in the same
manner as for HCF cells. HEK-293-T cells were transiently
transfected in six well plates for 48 h with 1 μg/well of a
pcDNA3_NPRA expression construct (kind gift from Dr
Michaela Kuhn, University of Wurzburg, Germany) or
empty vector using FuGENE (Roche) as recommended by
the manufacturer’s instructions.
Treatments
Where indicated, HCF cells were treated with 10 ng/mL
human recombinant TGFβ1 (R&D Systems) for 72 h.
For analysis of Smad phosphorylation, cells were treated
with TGFβ1 for 15 or 45 min. Human recombinant BNP
was purchased from American Peptide Company Inc.
HCF cells were treated with recombinant BNP at a con-
centration of 1000nM for 72 h. BNP was added to the
medium three times a day as previously described [13].
Mechanical stretch
All mechanical stretch experiments were carried out on
BioFlex six well culture plates (Dunn Labortechnik
GmbH) coated with 2 μg/cm2 human fibronectin
(Sigma). Cells were seeded and grown to a confluency of
approximately 70% on the fibronectin-coated BioFlex
culture plates prior to transfer onto the loading station
of the FX-4000 T mechanical stretch machine (Flexcell
International Corporation), and exposed to cyclic equi-
biaxial Heart Simulation strain (1 Hz, maximum elong-
ation 10%) for 72 h. Control plates were exposed to the
same conditions without being stretched.
Quantitative real-time PCR (QPCR)
RNA isolation from cells was achieved using NucleoSpin
RNA II Kit (Macherey-Nagel). First strand cDNA syn-
thesis was carried out using SuperScript II RT (Invitro-
gen). QPCR primers were designed so that one of each
primer pair was exon/exon boundary spanning to ensure
only mature mRNA was amplified. The sequences of the
gene-specific primers used are as follows; BNP, 5'-ACCG
CAAAATGGTCCTCTAC-3′ (forward), 5′- CGCCTCA
GCACTTTGCAG-3′ (reverse); NPR1, 5′-CGCAAAGG
CCGAGTTATCTA-3′ (forward), 5′-AACGTAGTCCTC
CCCACACA-3′ (reverse); ASMA, 5′-CGTTACTACTG
CTGAGCGTGA-3′ (forward), 5′-AACGTTCATTTCC
GATGGTG-3′ (reverse); collagen 1 α1 (COL1A1), 5′-G
AACGCGTGTCATCCCTTGT-3′ (forward), 5′-GAACG
AGGTAGTCTTTCAGCAACA-3′ (reverse); collagen 3
α1 (COL3A1), 5′- AACACGCAAGGCTGTGAGACT-
3′ (forward), 5′- GAACGAGGTAGTCTTTCAGCAAC
A-3′ (reverse); TGFβ, 5′-CGACTCGCCAGAGTGGTT
A-3′ (forward), 5′-GAACCCGTTGATGTCCACTT-3′
(reverse); TGFβ receptor type-1 (TGFβR1), 5′-ATTGCT
GGACCAGTGTGCTT-3′ (forward), 5′-AAACCTGAG
CCAGAACCTGA-3′ (reverse); TGFβ receptor type-2
(TGFβR2), 5′-AGTCGGATGTGGAAATGGAG-3′ (for-
ward), 5′-GCTCATGCAGGATTTCTGGT-3′ (reverse).
QPCR reactions were normalized by amplifying the
same cDNA with GAPDH primers, 5′-ACAGTCAGCC
GCATCTTCTT-3′ (forward), 5′-ACGACCAAATCCGT
TGACTC-3′ (reverse).
QPCR was performed using Platinum SYBR Green
qPCR SuperMix-UDG (Invitrogen). Amplification and
detection were carried out using Mx3000P System (Stra-
tagene). The PCR cycling program consisted of 40 three-
step cycles of 15 s/95 °C, 30 s/TA, and 30 s/72 °C. Each
sample was amplified in duplicate. In order to confirm
signal specificity, a melting program was carried out
after the PCR cycles were completed. The samples were
quantified by comparison with a standard calibration
curve created at the same time and the data was normal-
ized by an internal control (GAPDH).
Western blot analysis
Whole cell protein lysates were generated using RIPA
Lysis Buffer (Millipore), containing a protease inhibitor
cocktail (Roche). Protein concentrations were deter-
mined using the BCA Protein Assay Kit (Pierce). A total
of 10–50 μg of whole cell lysates were denatured,
reduced, and resolved on SDS-polyacrylamide gels by
SDS-PAGE before transfer onto 0.45 μm pore size
Immobilon-P polyvinylidene fluoride (PVDF) mem-
branes (Millipore).
Membranes were incubated with blocking buffer (TBS,
0.25% Tween-20, 0.1% serum from species that second-
ary antibody was raised in, and 10% fat-free skimmed
milk) for 1 h at room temperature. Membranes were
subsequently probed overnight with either anti-NPRA
(FabGennix Inc. International), anti-ASMA (Sigma),
anti-phospho Smad2 (Cell Signaling Technologies), anti-
total Smad2 (Cell Signaling Technologies), or anti-
phospho ERK (Cell Signaling Technologies). Detection
of the specific binding of the primary antibody was
achieved using HRP-conjugated secondary antibodies,
followed by signal detection with Immobilon Western
chemiluminescent HRP substrate (Millipore) according
to the manufacturer’s instructions. Anti-beta tubulin
(Sigma) was used to verify equal loading.
Immunoassay
Both total and active forms of TGFβ1 released by HCF
were quantified in cell supernatants. An acid activation
step was carried out for assessment of total TGFβ1. This
involved incubating the sample in 1 N HCl for 10 min at
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room temperature, followed by neutralization with 1.2 N
NaOH/0.5 M Hepes. This step was excluded when
assaying for active TGFβ1 within the cell culture super-
natant. Following sample preparation, TGFβ1 was quan-
tified using the human active TGFβ1 ultra-sensitive
immunoassay with electrochemiluminescence detection
as instructed by the manufacturer (Meso Scale Discov-
ery). This assay exhibits a large dynamic range suitable
for quantifying pg/mL concentrations in the superna-
tants of the cultured cardiac fibroblasts.
Immunofluorescence microscopy
HCF cells adhered to BioFlex wells were fixed in 4% par-
aformaldhyde for 20 min prior to being immuno-stained
with either anti-NPRA (1:25) or immunoglobulin control
at the same protein concentration, for 1 h at room
temperature. Fluorescent detection of NPRA was
achieved using Alexa Fluor 568 conjugated secondary
antibody (Invitrogen), followed by nuclear staining with
4'-6-diamidino-2-phenylindole (DAPI). The silicone
wells containing the immuno-stained cells were subse-
quently excised, mounted onto microscope slides, and
visualized using fluorescent microscopy (Zeiss Axio
Imager M1). Images were acquired at the same exposure
time for comparison.
Statistical analysis
Comparisons between the control and stretched groups
were made using independent t-test or ANOVA (Tukey
post-hoc analysis), where appropriate, with P values ≤0.05
considered statistically significant. All statistical calcula-
tions were performed using Graph Pad prism Software
(Version 4, San Diego, CA, USA).
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